Golub Capital has provided a USD23.5m one-loan debt financing to support Cortec Group’s acquisition of Katena Products.
Katena, based in Denville, New Jersey, is a producer and supplier of precision-manufactured micro instruments for ophthalmic surgeries of the anterior segment of the eye (i.e., cataracts, corneal transplants, Lasik, glaucoma).
Katena’s products are sold globally to hospitals, ambulatory surgery centres and individual ophthalmic surgeons.
"We are excited to be working again with Cortec, who has a lot of expertise and success in the medical device industry. We are pleased that we were able to provide them with a total solution to their financing needs," says Golub Capital senior managing director Greg Cashman. "Katena is a true leader in its field and we look forward to partnering with Cortec to build out the company’s capabilities and accelerate growth."
"Golub Capital was able to provide us with financing certainty in a very uncertain climate. They delivered on the terms they proposed and executed seamlessly. We are pleased to have a strong partner like Golub," adds Jonathan Stein, a senior managing director at Cortec Group.